| fluocinolone acetonide / Generic mfg. |
EMMA, NCT04910503: Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema |
|
|
| Recruiting | 4 | 106 | Europe | Dexamethasone intravitreal implant, Fluocinolone Acetonide Intravitreal Implant | Centre Hospitalier Universitaire Dijon | Diabetic Macular Edema | 04/30 | 04/30 | | |
NCT04636957: A Phase III Study of Ciprofloxacin Plus Fluocinolone in Acute Otitis Externa (AOE) |
|
|
| Not yet recruiting | 3 | 600 | RoW | Ciprofloxacin-Fluocinolone Acetonide, 0.3%-0.025% Otic Solution, Ciprofloxacin 0.3% solution, CETRAXAL OTICO® | Lee's Pharmaceutical Limited | Acute Otitis Externa | 12/21 | 07/22 | | |
ChiCTR1900026160: A Phase III, Multi-Center, Randomized, Double-Blind, Controlled, Safety and Efficacy Study for a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye |
|
|
| Recruiting | 3 | 150 | | Intravitreal FAI insert ;Sham Injection | The First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Chongqing Medical University, Fully self-raised | uveitis | | | | |
ACTRN12605000485639: A Multicenter, Randomized, Double-Masked Controlled Study to Evaluate the Safety and Efficacy of an Intravitreal Fluocinolone Acetonide (0.59 and 2.1 mg) Implant in Patients with Non-Infectious Uveitis Affecting the Posterior Segment of the Eye |
|
|
| Active, not recruiting | 2/3 | 40 | | | Bausch & Lomb (Rochester), Bausch & Lomb (Rochester) | Non-infectious Posterior Uveitis | | | | |
NCT06013540: Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma. |
|
|
| Active, not recruiting | 2 | 122 | RoW | TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C), Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%) | Jinnah Postgraduate Medical Centre | Melasma | 12/22 | 08/23 | | |
2005-001589-15: A multi-center study evaluating the safety of a replacement intravitreal fluocinolone acetonide (FA) (0.59 mg) implant in patients with non-infectious posterior uveitis who were previously treated with an intravitreal FA implant |
|
|
| Ongoing | 1 | 7 | Europe | Fluocinolone Acetonide 0.59mg Intravitreal Implant, | Bausch & Lomb Incorporated | Non-infectious Uveitis affecting posterior segment of the eye | | | | |
| Recruiting | N/A | 30 | US | Fluocinolone Acetonide | The Cleveland Clinic | Uveitis | 01/25 | 03/25 | | |
| Recruiting | N/A | 34 | Europe | ACF injection | Nantes University Hospital | Macular Edema | 06/24 | 06/24 | | |
ChiCTR2300069849: Real world data study on the treatment of chronic noninfectious uveitis involving the posterior segment of the eye with Fluocinolone Acetonide Intravitreal (FAI) Insert |
|
|
| Recruiting | N/A | 400 | | Intravitreal FAI insert ;None | Boao Super Hospital; Ocumension Therapeutics (Shanghai) Co., Ltd., enterprise（Ocumension Therapeutics (Shanghai) Co., Ltd） | uveitis | | | | |
